Abstract
Faculty Opinions recommendation of LB 01.2 - Emicizumab prophylaxis instead of immunosuppressive therapy in patients with acquired hemophilia A (AHA).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have